Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

03 Feb 2022 at 00:00

OJEU - F3 - Contract Award Notice
Tender

24 Sep 2021 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The procurement process is led by The Common Services Agency, also known as NHS National Services Scotland, which seeks to establish a framework agreement for the supply of Analgesics, Anaesthetics, and Musculoskeletal & Joint Disease Generic Medicines. The tender is categorised under goods within the health industry and is located in Edinburgh, Scotland. The process is currently at the award stage, with key contracts signed on 21st December 2021, covering four main lots. This open procurement method initiated a tender that was active until 27th October 2021, indicating a comprehensive evaluation of submitted bids from potential suppliers.

This tender offers significant opportunities for businesses, particularly those specialising in pharmaceuticals and healthcare products. Suppliers capable of providing the specified generic medicines will find their expertise valuable in this competitive environment. Companies with a solid background in the pharmaceutical sector, especially those with the ability to meet the stringent quality and regulatory standards outlined in the tender, will be well-suited to participate in this framework agreement. A variety of businesses, including large pharmaceutical firms and SMEs with niche capabilities, could leverage this contract to strengthen their position within the public health supply chain.

How relevant is this notice?

Notice Information

Notice Title

Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

Notice Description

This framework agreement is for the Supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to NHS Scotland. The Goods have been separated into four (4) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Baclofen Intrathecal Injections

Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection

The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

All Other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines

Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines in a range of presentations. Each product line was treated as an individual Lot, and the Authority has awarded each lot to a single framework participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Levobupivacaine (As Hydrochloride) Solution For Infusion

The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000663589
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB439531
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£19,205,951 £10M-£100M
Lots Value
£19,205,951 £10M-£100M
Awards Value
Not specified
Contracts Value
£14,625,036 £10M-£100M

Notice Dates

Publication Date
3 Feb 20224 years ago
Submission Deadline
27 Oct 2021Expired
Future Notice Date
Not specified
Award Date
21 Dec 20214 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
32
Supplier Names

Accord-UK Ltd

Aguettant Ltd

Altan Pharma Ltd

Arcadia Pharma Limited T/A Arcadia Medical

Aspen Pharma Ireland Ltd

Crescent Pharma Limited

DRUGSRUS LTD

Focus Pharmaceuticals Ltd

Fresenius Kabi Limited

GSK UK Limited

Glenmark Pharmaceuticals Europe Ltd

Kent Pharmaceuticals Ltd

Martindale Pharma

Mercury Pharma Group

Morningside Pharmaceuticals Limited

Mylan

Neuraxpharm UK Ltd

Panpharma UK Ltd

Pfizer Limited

Phoenix Labs

Ranbaxy (UK) Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Tetris Pharma Ltd

Teva UK Limited

Thornton & Ross Ltd

Typharm Ltd

V Pharma Ltd

Wockhardt UK Limited

Zentiva Pharma UK Ltd

hameln pharma ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...